No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs182306308 |
chr11:104787480-104787481 |
Enhancers Weak transcription Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs530712233 |
chr11:104787530-104787531 |
Enhancers Weak transcription Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs77559258 |
chr11:104787532-104787533 |
Enhancers Weak transcription Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs572712495 |
chr11:104787559-104787560 |
Enhancers Weak transcription Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs12294079 |
chr11:104787564-104787565 |
Enhancers Weak transcription Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs10466555 |
chr11:104787578-104787579 |
Enhancers Weak transcription Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs187502392 |
chr11:104787624-104787625 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs554257708 |
chr11:104787632-104787633 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs71471748 |
chr11:104787662-104787663 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs10466650 |
chr11:104787664-104787665 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
11 |
rs560134834 |
chr11:104787668-104787669 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs532008401 |
chr11:104787675-104787676 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs545689801 |
chr11:104787689-104787690 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs111959719 |
chr11:104787759-104787760 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs531146626 |
chr11:104787869-104787870 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs551168808 |
chr11:104787871-104787872 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs201144823 |
chr11:104787878-104787879 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs72116027 |
chr11:104787879-104787880 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs200921897 |
chr11:104787884-104787885 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs113734694 |
chr11:104787902-104787903 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs530249906 |
chr11:104787906-104787907 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs546767257 |
chr11:104787936-104787937 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs550829445 |
chr11:104787938-104787939 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs193267279 |
chr11:104787988-104787989 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs538609264 |
chr11:104788001-104788002 |
Weak transcription Flanking Active TSS Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs147242300 |
chr11:104788013-104788014 |
Weak transcription Flanking Active TSS Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs520173 |
chr11:104788061-104788062 |
Weak transcription Flanking Active TSS Enhancers Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
28 |
rs537670486 |
chr11:104788099-104788100 |
Weak transcription Flanking Active TSS Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs75246162 |
chr11:104788134-104788135 |
Weak transcription Flanking Active TSS Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs574283935 |
chr11:104788135-104788136 |
Weak transcription Flanking Active TSS Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs533936039 |
chr11:104788148-104788149 |
Weak transcription Flanking Active TSS Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs555122234 |
chr11:104788199-104788200 |
Weak transcription Flanking Active TSS Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs12282244 |
chr11:104788252-104788253 |
Weak transcription Flanking Active TSS Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs648421 |
chr11:104788304-104788305 |
Weak transcription Flanking Active TSS Active TSS Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
35 |
rs185678225 |
chr11:104788313-104788314 |
Weak transcription Flanking Active TSS Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs518128 |
chr11:104788337-104788338 |
Weak transcription Flanking Active TSS Active TSS Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
37 |
rs75145264 |
chr11:104788338-104788339 |
Weak transcription Flanking Active TSS Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs78401313 |
chr11:104788353-104788354 |
Weak transcription Flanking Active TSS Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs558934056 |
chr11:104788354-104788355 |
Weak transcription Flanking Active TSS Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs76389443 |
chr11:104788456-104788457 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs547070644 |
chr11:104788474-104788475 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs373156263 |
chr11:104788517-104788518 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs532553560 |
chr11:104788572-104788573 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs552259322 |
chr11:104788579-104788580 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs141563732 |
chr11:104788588-104788589 |
Active TSS Flanking Active TSS Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs537790067 |
chr11:104788607-104788608 |
Active TSS Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs577421613 |
chr11:104788636-104788637 |
Active TSS Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs567917790 |
chr11:104788693-104788694 |
Active TSS Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs533710882 |
chr11:104788694-104788695 |
Active TSS Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs514537 |
chr11:104788727-104788728 |
Active TSS Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|